3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Thoracic
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Prostatic Neoplasms
1754
Urinary Bladder Neoplasms
351
Carcinoma, Renal Cell
217
Breast Neoplasms
210
Neoplasms
164
Kidney Neoplasms
158
Lung Neoplasms
101
Colorectal Neoplasms
95
Motor Activity
85
Testicular Neoplasms
60
Ovarian Neoplasms
53
Colonic Neoplasms
48
Melanoma
47
Pancreatic Neoplasms
44
Neoplasm Metastasis
43
Non-Muscle Invasive Bladder Neoplasms
42
Urinary Incontinence
40
Head and Neck Neoplasms
40
Uterine Cervical Neoplasms
39
Disease
39
Carcinoma, Transitional Cell
39
Sarcoma
37
Urologic Neoplasms
36
Recurrence
35
Anxiety Disorders
32
Stomach Neoplasms
29
Carcinoma, Non-Small-Cell Lung
29
Lymphoma
28
Endometrial Neoplasms
28
Prostatic Hyperplasia
27
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Atrial Fibrillation
×
Genitourinary
×
Clear all
NCT04331535
2022-10-03
GenoVA
Boston VA Research Institute, Inc.
Phase NA
Unknown
1,076 enrolled